ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382053; 2) Community: the network communities that were significantly associated with the response to NSC 382053; 3) Molecule: the relationships between components within communities and NSC 382053; 4) MDR: the compounds that were significantly associated with the NSC 382053.

NSC Compound Enrichment Correlation
NSC 756158 GSK237700A 0.0423559437159349 0.25835896
NSC 756220 GW396574X 0.0423559437159349 0.26999324
NSC 756258 GW569530A 0.0423559437159349 -0.35424848
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0423559437159349 0.29366841
NSC 106995 U 24792 0.0457230037898008 0.43799037
NSC 112535 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-[m-[2-(p-nitro-phenoxy)ethoxy]phenyl]-, monohydrochloride (8CI) 0.0457230037898008 0.41289015
NSC 142587 Null 0.0457230037898008 0.45020584
NSC 205795 Benzoic acid, 4-[[(2-thiazolylamino)carbonyl]amino]-, ethyl ester (9CI) 0.0457230037898008 0.3337466
NSC 271967 Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) 0.0457230037898008 0.32659276
NSC 307241 Adriamycin deriv., mixt. with hydroxyethyl starch (cross-linked) 0.0457230037898008 0.31088285
Total:136  Current:130    [First] [Prev] [Next] [Last]